Literature DB >> 21976607

Human Metapneumovirus: lessons learned over the first decade.

Verena Schildgen1, Bernadette van den Hoogen, Ron Fouchier, Ralph A Tripp, Rene Alvarez, Catherine Manoha, John Williams, Oliver Schildgen.   

Abstract

It has been 10 years since human metapneumovirus (HMPV) was identified as a causative agent of respiratory illness in humans. Since then, numerous studies have contributed to a substantial body of knowledge on many aspects of HMPV. This review summarizes our current knowledge on HMPV, HMPV disease pathogenesis, and disease intervention strategies and identifies a number of areas with key questions to be addressed in the future.

Entities:  

Mesh:

Year:  2011        PMID: 21976607      PMCID: PMC3194831          DOI: 10.1128/CMR.00015-11

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  259 in total

1.  Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH.

Authors:  Rachel M Schowalter; Stacy E Smith; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

2.  Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.

Authors:  Gabriella Cseke; David W Wright; Sharon J Tollefson; Joyce E Johnson; James E Crowe; John V Williams
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

Review 3.  Animal models for human metapneumovirus (HMPV) infections.

Authors:  Oliver Schildgen; Arne Simon; John Williams
Journal:  Vet Res       Date:  2006-12-21       Impact factor: 3.683

4.  Absence of human metapneumovirus co-infection in cases of severe respiratory syncytial virus infection.

Authors:  J B M van Woensel; A P Bos; R Lutter; J W A Rossen; R Schuurman
Journal:  Pediatr Pulmonol       Date:  2006-09

5.  Multi-year study of human metapneumovirus infection at a large US Midwestern Medical Referral Center.

Authors:  Gregory C Gray; Ana W Capuano; Sharon F Setterquist; Dean D Erdman; Newell D Nobbs; Yacine Abed; Gary V Doern; Sarah E Starks; Guy Boivin
Journal:  J Clin Virol       Date:  2006-09-27       Impact factor: 3.168

6.  Human metapneumovirus infection among children in Taiwan: a comparison of clinical manifestations with other virus-associated respiratory tract infections.

Authors:  S-M Wang; C-C Liu; H-C Wang; I-J Su; J-R Wang
Journal:  Clin Microbiol Infect       Date:  2006-12       Impact factor: 8.067

7.  Serosurvey of human metapneumovirus infection in Croatia.

Authors:  Suncanica Ljubin Sternak; Tatjana Vilibić Cavlek; Ann R Falsey; Edward E Walsh; Gordana Mlinarić Galinović
Journal:  Croat Med J       Date:  2006-12       Impact factor: 1.351

8.  Human metapneumovirus, Australia, 2001-2004.

Authors:  Theo P Sloots; Ian M Mackay; Seweryn Bialasiewicz; Kevin C Jacob; Emily McQueen; Gerald B Harnett; David J Siebert; Brent I Masters; Paul R Young; Michael D Nissen
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

9.  Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease.

Authors:  Richard A Martinello; Frank Esper; Carla Weibel; David Ferguson; Marie L Landry; Jeffrey S Kahn
Journal:  J Infect       Date:  2006-01-10       Impact factor: 6.072

10.  Prevalence and clinical characteristics of human metapneumovirus infections in hospitalized infants in Spain.

Authors:  M L García-García; C Calvo; P Pérez-Breña; J M De Cea; B Acosta; I Casas
Journal:  Pediatr Pulmonol       Date:  2006-09
View more
  88 in total

Review 1.  Recent vaccine development for human metapneumovirus.

Authors:  J Ren; T Phan; X Bao
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

Review 2.  New Approaches for Immunization and Therapy against Human Metapneumovirus.

Authors:  Sherry C Wen; John V Williams
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

3.  Regulation of paramyxovirus fusion activation: the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state.

Authors:  Matteo Porotto; Zuhair W Salah; Long Gui; Ilaria DeVito; Eric M Jurgens; Hong Lu; Christine C Yokoyama; Laura M Palermo; Kelly K Lee; Anne Moscona
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

Review 4.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

5.  A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus In Vivo.

Authors:  Yael Bar-Peled; Darren Diaz; Alma Pena-Briseno; Jackelyn Murray; Jiachen Huang; Ralph A Tripp; Jarrod J Mousa
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

6.  Human metapneumovirus G protein is highly conserved within but not between genetic lineages.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Linda D Lintao; Alexis Liem; Marla Chu; John V Williams
Journal:  Arch Virol       Date:  2013-02-06       Impact factor: 2.574

7.  Role of dietary antioxidants in human metapneumovirus infection.

Authors:  Narayana Komaravelli; John P Kelley; Matteo P Garofalo; Haotian Wu; Antonella Casola; Deepthi Kolli
Journal:  Virus Res       Date:  2015-01-30       Impact factor: 3.303

Review 8.  Human metapneumovirus.

Authors:  Jennifer E Schuster; John V Williams
Journal:  Pediatr Rev       Date:  2013-12

9.  Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo.

Authors:  M Del Rocío Baños-Lara; Arpita Ghosh; Antonieta Guerrero-Plata
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

10.  A prospective study of agents associated with acute respiratory infection among young American Indian children.

Authors:  Niranjan Bhat; Rafal Tokarz; Komal Jain; Saddef Haq; Robert Weatherholtz; Aruna Chandran; Ruth Karron; Raymond Reid; Mathuram Santosham; Katherine L O'Brien; W Ian Lipkin
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.